+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Corticosteroids Global Market Report 2021: COVID-19 Implications and Growth to 2030

  • ID: 5317316
  • Report
  • April 2021
  • Region: Global
  • The Business Research Company

FEATURED COMPANIES

  • Abbott Laboratories
  • Bayer
  • GSK
  • LEO Pharma
  • Novartis
  • Sanofi
Corticosteroids Global Market Report 2021: COVID-19 Implications and Growth to 2030 covers this critical market and the impact on it from the COVID-19 virus. It provides strategists, marketers and senior management with the critical information they need to assess the increasing demand for corticosteroids which play a critical role in the treatment of patients with COVID-19.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 20+ geographies.
  • Understand how the market is experiencing rapid growth due to the coronavirus and how it is likely to stabilize as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Description:

Where is the largest and fastest growing market for the corticosteroids therapy? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Corticosteroids Therapy market global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider corticosteroids therapy market, and compares it with other markets.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The corticosteroids therapy market section of the report gives context. It compares the corticosteroids therapy market with other segments of the corticosteroids therapy market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, corticosteroids therapy indicators comparison.
Scope

Markets Covered:

1) By Product: Glucocorticoids; Mineralocorticoids
2) By Application: Skin Allergies; Rhuematology Indications; Endocrinology; Acute Respiratory Diseases; Others
3) By End User: Hospitals; Clinics; Research Institutes; Others

Companies Mentioned: Sumitomo; Pfizer; Novartis; Merck; Sanofi

Countries: Brazil; China; France; Germany; India; Indonesia; Japan; South Korea; Russia; UK; USA; Australia

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, per capita expenditure.

Data Segmentations: Country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

This report will be delivered within 1-3 business days.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • Bayer
  • GSK
  • LEO Pharma
  • Novartis
  • Sanofi
1. Executive Summary

2. Corticosteroids Therapy Market Characteristics

3. Corticosteroids Therapy Market Trends And Strategies

4. Impact Of COVID-19 On Corticosteroids Therapy

5. Corticosteroids Therapy Market Size And Growth
5.1. Global Corticosteroids Therapy Historic Market, 2015-2020, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Corticosteroids Therapy Forecast Market, 2020-2025F, 2030F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market

6. Corticosteroids Therapy Market Segmentation
6.1. Global Corticosteroids Therapy Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Glucocorticoids
  • Mineralocorticoids
6.2. Global Corticosteroids Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Skin Allergies
  • Rhuematology Indications
  • Endocrinology
  • Acute Respiratory Diseases
  • Others
6.3. Global Corticosteroids Therapy Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Hospitals
  • Clinics
  • Research Institutes
  • Others
7. Corticosteroids Therapy Market Regional And Country Analysis
7.1. Global Corticosteroids Therapy Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
7.2. Global Corticosteroids Therapy Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

8. Asia-Pacific Corticosteroids Therapy Market
8.1. Asia-Pacific Corticosteroids Therapy Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Corticosteroids Therapy Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

9. China Corticosteroids Therapy Market
9.1. China Corticosteroids Therapy Market Overview
9.2. China Corticosteroids Therapy Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

10. India Corticosteroids Therapy Market
10.1. India Corticosteroids Therapy Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

11. Japan Corticosteroids Therapy Market
11.1. Japan Corticosteroids Therapy Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

12. Australia Corticosteroids Therapy Market
12.1. Australia Corticosteroids Therapy Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

13. Indonesia Corticosteroids Therapy Market
13.1. Indonesia Corticosteroids Therapy Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

14. South Korea Corticosteroids Therapy Market
14.1. South Korea Corticosteroids Therapy Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

15. Western Europe Corticosteroids Therapy Market
15.1. Western Europe Corticosteroids Therapy Market Overview
15.2. Western Europe Corticosteroids Therapy Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

16. UK Corticosteroids Therapy Market
16.1. UK Corticosteroids Therapy Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

17. Germany Corticosteroids Therapy Market
17.1. Germany Corticosteroids Therapy Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

18. France Corticosteroids Therapy Market
18.1. France Corticosteroids Therapy Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

19. Eastern Europe Corticosteroids Therapy Market
19.1. Eastern Europe Corticosteroids Therapy Market Overview
19.2. Eastern Europe Corticosteroids Therapy Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

20. Russia Corticosteroids Therapy Market
20.1. Russia Corticosteroids Therapy Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

21. North America Corticosteroids Therapy Market
21.1. North America Corticosteroids Therapy Market Overview
21.2. North America Corticosteroids Therapy Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

22. USA Corticosteroids Therapy Market
22.1. USA Corticosteroids Therapy Market Overview
22.2. USA Corticosteroids Therapy Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

23. South America Corticosteroids Therapy Market
23.1. South America Corticosteroids Therapy Market Overview
23.2. South America Corticosteroids Therapy Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

24. Brazil Corticosteroids Therapy Market
24.1. Brazil Corticosteroids Therapy Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

25. Middle East Corticosteroids Therapy Market
25.1. Middle East Corticosteroids Therapy Market Overview
25.2. Middle East Corticosteroids Therapy Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

26. Africa Corticosteroids Therapy Market
26.1. Africa Corticosteroids Therapy Market Overview
26.2. Africa Corticosteroids Therapy Market, Segmentation By Product, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

27. Corticosteroids Therapy Market Competitive Landscape And Company Profiles
27.1. Corticosteroids Therapy Market Competitive Landscape
27.2. Corticosteroids Therapy Market Company Profiles
27.2.1. Sumitomo
27.2.1.1. Overview
27.2.1.2. Products and Services
27.2.1.3. Strategy
27.2.1.4. Financial Performance
27.2.2. Pfizer
27.2.2.1. Overview
27.2.2.2. Products and Services
27.2.2.3. Strategy
27.2.2.4. Financial Performance
27.2.3. Novartis
27.2.3.1. Overview
27.2.3.2. Products and Services
27.2.3.3. Strategy
27.2.3.4. Financial Performance
27.2.4. Merck
27.2.4.1. Overview
27.2.4.2. Products and Services
27.2.4.3. Strategy
27.2.4.4. Financial Performance
27.2.5. Sanofi
27.2.5.1. Overview
27.2.5.2. Products and Services
27.2.5.3. Strategy
27.2.5.4. Financial Performance

28. Corticosteroids Therapy Pipeline Analysis

29. Key Mergers And Acquisitions In The Corticosteroids Therapy Market

30. Corticosteroids Therapy Market Future Outlook and Potential Analysis

31. Appendix
31.1. Abbreviations
31.2. Currencies
31.3. Research Inquiries
31.4. About the Publisher
31.5. Copyright And Disclaimer
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • Bayer
  • GSK
  • LEO Pharma
  • Novartis
  • Sanofi
Major players in the corticosteroids therapy market are Sumitomo, Pfizer, Novartis, Merck, Sanofi, Johnson and Johnson, GSK, AstraZeneca, Cipla, and LEO Pharma.

The global corticosteroids market is expected to grow from $4.47 billion in 2020 to $4.56 billion in 2021 at a compound annual growth rate (CAGR) of 2%. The change in growth trend is mainly due to the companies stabilizing their output after catering to the demand that grew exponentially during the COVID-19 pandemic in 2020. The market is expected to reach $5.33 billion in 2025 at a CAGR of 4%.

The corticosteroids therapy market consists of sales of synthetic corticosteroid drugs used to treat a wide variety of disorders, including asthma, arthritis, skin conditions, autoimmune diseases and lowers inflammation in the body. Corticosteroids and their biologically active synthetic derivatives differ in their metabolic (glucocorticoid) and electrolyte-regulating (mineralocorticoid) activities. These agents are employed at physiological doses for replacement therapy when endogenous production is impaired. The market consists of revenue generated by the company’s manufacturing synthetic corticosteroids by the sales of these products.

The SARS-CoV outbreak research studies show that corticosteroids as adjunctive therapy may be beneficial to treat corona viruses if utilized in the early acute phase of infection. The use of corticosteroids during the treatment of coronaviruses have shown positive outcomes due to their ability to modulate the inflammatory response. Therefore, corticosteroids market has experienced a surge in its growth.

Side effects associated with the long-term use of corticosteroids is negatively affecting the corticosteroids market. More recently, in a meta-analysis that included 28 studies (2,382 patients), the overall risk of adverse events was 150 per 100 patient-years. Psychological and behavioural adverse events (e.g., minor mood disturbances) were reported most frequently, followed by gastrointestinal events (e.g., dyspepsia and dysphagia). Infectious complications included bacterial infections; reactivation of tuberculosis or toxoplasmosis; and viral infections, including herpes virus, varicella zoster virus, and reactivation of viral hepatitis. The association between corticosteroid therapy and subsequent infections was calculated by pooling data from 71 controlled clinical trials. The overall rate of infectious complications was 12.7% in the 2,111 patients randomly allocated to systemic corticosteroids and 8.0% in the 2,087 controls. The risk of infection was particularly high in patients with neurologic diseases and less pronounced in patients with intestinal, hepatic, and renal diseases. The rate was not increased in patients given a daily dose of < 10 mg or a cumulative dose of < 700 mg of prednisone. With increasing doses, the rate of occurrence of infectious complications increased in patients given corticosteroids as well as in patients given placebo, a finding suggesting that not only the corticosteroid but also the underlying disease state account for the steroid-associated infectious complications observed in clinical practice. Adverse and unwanted effects due to the use of corticosteroids has a negative impact on the corticosteroid market.

The development of silicones for topical and transdermal drug delivery is one of the key trends in corticosteroid therapy market. Silicone gel sheets are soft wound covers composed of cross-linked polymers reinforced with or bonded to mesh or fabric. A new strategy to deliver drugs to the inner ear from dexamethasone (DXM)-loaded silicone implants and to evaluate the distribution of the drug in the cochlea with confocal microscopy and development of a new device for local corticosteroids delivery into the oval window with an extended drug release of DXM to the inner ear is also seen in recent years. Silicone gel sheeting is also an excellent treatment option for paediatric patients who may not be able to tolerate intralesional corticosteroid injection. Silicone-based pressure-sensitive adhesives for transdermal drug delivery has shown higher diffusivity and greater skin permeation rate. Silicones offer several advantages such as improved drug permeability, high diffusivity and offer efficient function and performance to modern drug products.

Sanofi is in talks to buy Flexion Therapeutics. Flexion’s knee injection for osteoarthritis, Zilretta (sustained release corticosteroid), would fit right in with Sanofi’s biosurgery division, which markets its own osteoarthritis injectable, Synvisc. Zilretta is a sustained-release corticosteroid first up for approval for use in the knee. Analysts have suggested it could bring in $500 million to $600 million in peak sales, and perhaps hit blockbuster status if it wins indications for use in other joints.

Increasing prevalence of Skin related disease and the rising incidences of rashes, dermatitis, itching, eczema, and psoriasis contributed to the growth of the corticosteroids market. According to the CDC (Center for Disease Control), each year in the US, at least 2 million people are infected with bacteria that are resistant to antibiotics, and at least 23,000 people die due to such infections. According to the European Academy of Dermatology and Venereology report in 2019, of the 2,701 individuals in the survey, at least one skin disorder was found in 1,662 participants (64.5%). Rosacea (25.5%), eczema (11.7%), Actinic keratosis (26.6%) were the most prominent diagnoses. Skin disorders increased with age and were more prevalent in men (72.3%) than in women (58.0%). The increased prevalence of such disorders increased the demand for corticosteroids, driving the market.
Note: Product cover images may vary from those shown
  • Sumitomo
  • Pfizer
  • Novartis
  • Merck
  • Sanofi
  • Johnson and Johnson
  • GSK
  • AstraZeneca
  • Cipla
  • LEO Pharma
  • Abbott Laboratories
  • Bayer
  • Zizhu Pharma
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll